European Journal of Cell Biology (Jun 2024)

Crystal structure of NRAS Q61K with a ligand-induced pocket near switch II

  • Teklab Gebregiworgis,
  • Jonathan Yui-Lai Chan,
  • Douglas A. Kuntz,
  • Gilbert G. Privé,
  • Christopher B. Marshall,
  • Mitsuhiko Ikura

Journal volume & issue
Vol. 103, no. 2
p. 151414

Abstract

Read online

The RAS isoforms (KRAS, HRAS and NRAS) have distinct cancer type-specific profiles. NRAS mutations are the second most prevalent RAS mutations in skin and hematological malignancies. Although RAS proteins were considered undruggable for decades, isoform and mutation-specific investigations have produced successful RAS inhibitors that are either specific to certain mutants, isoforms (pan-KRAS) or target all RAS proteins (pan-RAS). While extensive structural and biochemical investigations have focused mainly on K- and H-RAS mutations, NRAS mutations have received less attention, and the most prevalent NRAS mutations in human cancers, Q61K and Q61R, are rare in K- and H-RAS. This manuscript presents a crystal structure of the NRAS Q61K mutant in the GTP-bound form. Our structure reveals a previously unseen pocket near switch II induced by the binding of a ligand to the active form of the protein. This observation reveals a binding site that can potentially be exploited for development of inhibitors against mutant NRAS. Furthermore, the well-resolved catalytic site of this GTPase bound to native GTP provides insight into the stalled GTP hydrolysis observed for NRAS-Q61K.

Keywords